Clinical Trials Browser

Phase 2 × vatalanib × Classical hematology × Clear all

NCT00072475 2016-08-01

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases